Search results
Maintenance Tx With Guselkumab for UC Meets All Endpoints
Medscape· 4 days agoGuselkumab (Tremfya, Janssen/Johnson & Johnson) was superior to placebo for maintenance therapy in...
7 Biotech Stocks That Could Breathe New Life Into Your Portfolio
InvestorPlace· 5 days agoFundamentally, one of the biggest advantages of biotech stocks to buy centers on the underlying...
Guselkumab Continues Winning Streak in Crohn's Disease
MedPage Today· 4 days agoInduction and maintenance treatment with guselkumab (Tremfya) demonstrated its safety and efficacy...
Alvotech (ALVO) Scheduled to Post Quarterly Earnings on Tuesday
ETF DAILY NEWS· 7 days agoAlvotech (NYSE:ALVO – Get Free Report) will post its quarterly earnings results after the market closes on Tuesday, May 21st. Individual interested in participating in the company’s earnings ...
Research shows linked biological pathways driving skin inflammation
Medical Xpress· 5 days agoInflammation is the body's natural response to irritation and infection, but when out of control, it...
AbbVie (NYSE:ABBV) vs. Cosmo Pharmaceuticals (OTC:CMOPF) Head to Head Review
ETF DAILY NEWS· 17 hours agoAbbVie (NYSE:ABBV – Get Free Report) and Cosmo Pharmaceuticals (OTC:CMOPF – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses ...
AbbVie (NYSE:ABBV) Shares Down 0.1%
ETF DAILY NEWS· 10 hours agoAbbVie Inc. (NYSE:ABBV – Get Free Report)’s stock price dropped 0.1% during mid-day trading on Thursday . The stock traded as low as $157.76 and last traded at $159.38. Approximately 903,885 ...
Amgen Inc. (NASDAQ:AMGN) Holdings Cut by Panagora Asset Management Inc.
ETF DAILY NEWS· 6 days agoPanagora Asset Management Inc. decreased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 9.1% in the fourth quarter, according to the company in its most recent disclosure ...
Jump Financial LLC Has $369,000 Stock Position in Acelyrin, Inc. (NASDAQ:SLRN)
ETF DAILY NEWS· 14 hours agoJump Financial LLC lifted its stake in shares of Acelyrin, Inc. (NASDAQ:SLRN – Free Report) by 152.7% during the fourth quarter, according to the company in its most recent filing with the Securities ...
Bristol-Myers Squibb (NYSE:BMY) Shares Down 1.1%
ETF DAILY NEWS· 10 hours agoShares of Bristol-Myers Squibb (NYSE:BMY – Get Free Report) fell 1.1% during trading on Thursday . The company traded as low as $41.58 and last traded at $41.89. 3,501,801 shares changed hands ...
